# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-040321
Filing Date
2025-03-17
Accepted
2025-03-17 16:26:33
Documents
55
Period of Report
2025-03-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | rgen-20250317.htm iXBRL | PRE 14A | 3919324
2 | GRAPHIC | img35436345_0.jpg | GRAPHIC | 28737
3 | GRAPHIC | img35436345_1.jpg | GRAPHIC | 38034
4 | GRAPHIC | img35436345_2.jpg | GRAPHIC | 41712
5 | GRAPHIC | img35436345_3.jpg | GRAPHIC | 41712
6 | GRAPHIC | img35436345_4.jpg | GRAPHIC | 21046
7 | GRAPHIC | img35436345_5.jpg | GRAPHIC | 33119
8 | GRAPHIC | img35436345_6.jpg | GRAPHIC | 39248
9 | GRAPHIC | img35436345_7.jpg | GRAPHIC | 32374
10 | GRAPHIC | img35436345_8.jpg | GRAPHIC | 336313
11 | GRAPHIC | img35436345_9.jpg | GRAPHIC | 412329
12 | GRAPHIC | img35436345_10.jpg | GRAPHIC | 341584
13 | GRAPHIC | img35436345_11.jpg | GRAPHIC | 361998
14 | GRAPHIC | img35436345_12.jpg | GRAPHIC | 345428
15 | GRAPHIC | img35436345_13.jpg | GRAPHIC | 419379
16 | GRAPHIC | img35436345_14.jpg | GRAPHIC | 462710
17 | GRAPHIC | img35436345_15.jpg | GRAPHIC | 21377
18 | GRAPHIC | img35436345_16.jpg | GRAPHIC | 27498
19 | GRAPHIC | img35436345_17.jpg | GRAPHIC | 70896
20 | GRAPHIC | img35436345_18.jpg | GRAPHIC | 98780
21 | GRAPHIC | img35436345_19.jpg | GRAPHIC | 485083
22 | GRAPHIC | img35436345_20.jpg | GRAPHIC | 390012
23 | GRAPHIC | img35436345_21.jpg | GRAPHIC | 562541
24 | GRAPHIC | img35436345_22.jpg | GRAPHIC | 455923
25 | GRAPHIC | img35436345_23.jpg | GRAPHIC | 457152
26 | GRAPHIC | img35436345_24.jpg | GRAPHIC | 501273
27 | GRAPHIC | img35436345_25.jpg | GRAPHIC | 166932
28 | GRAPHIC | img35436345_26.jpg | GRAPHIC | 474872
29 | GRAPHIC | img35436345_27.jpg | GRAPHIC | 284385
30 | GRAPHIC | img35436345_28.jpg | GRAPHIC | 462710
31 | GRAPHIC | img35436345_29.jpg | GRAPHIC | 336313
32 | GRAPHIC | img35436345_30.jpg | GRAPHIC | 412329
33 | GRAPHIC | img35436345_31.jpg | GRAPHIC | 341584
34 | GRAPHIC | img35436345_32.jpg | GRAPHIC | 361998
35 | GRAPHIC | img35436345_33.jpg | GRAPHIC | 345428
36 | GRAPHIC | img35436345_34.jpg | GRAPHIC | 419379
37 | GRAPHIC | img35436345_35.jpg | GRAPHIC | 31555
38 | GRAPHIC | img35436345_36.jpg | GRAPHIC | 31217
39 | GRAPHIC | img35436345_37.jpg | GRAPHIC | 30294
40 | GRAPHIC | img35436345_38.jpg | GRAPHIC | 24913
41 | GRAPHIC | img35436345_39.jpg | GRAPHIC | 139501
42 | GRAPHIC | img35436345_40.jpg | GRAPHIC | 151663
| Complete submission text file | 0000950170-25-040321.txt |  | 31395886

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
43 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rgen-20250317.xsd | EX-101.SCH | 19545
57 | EXTRACTED XBRL INSTANCE DOCUMENT | rgen-20250317_htm.xml | XML | 665545

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-14656 | Film No.: 25744866
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)